Hep A Vaccination Safety During Pregnancy: What's The Verdict?

Hepatitis A is an acute, short-term form of viral hepatitis that can be passed from one person to another through contact with infected faeces. It is usually mild and self-limiting in healthy adults, but it can pose serious health concerns in pregnant people. Hepatitis A in pregnancy may lead to preterm birth, leakage of amniotic fluid, and premature separation of the placenta, among other concerns. Contracting hepatitis A during pregnancy can increase the risk of complications like preterm birth. However, the hepatitis A vaccine is safe for use during pregnancy and is recommended for pregnant people with a high risk of hepatitis A-related pregnancy complications.

Hepatitis A infection during pregnancy is not believed to pose a risk to embryofetal development

To reduce the risk of contracting hepatitis A while travelling to endemic areas, it is important to maintain hygienic practices such as hand washing with safe water, particularly before handling food, avoiding drinking water or using ice cubes of unknown purity, and avoiding eating unpeeled fruits and vegetables. A hepatitis A vaccine is available and can be administered before travelling to endemic countries. The vaccine is produced from an inactivated virus, and while the safety of hepatitis A vaccination during pregnancy has not been determined, the theoretical risk to the developing foetus is expected to be low.

Hepatitis A infection during pregnancy is the most common cause of acute viral hepatitis in the general population but is infrequently reported among pregnant women. Data on the incidence and outcome of hepatitis A infection during pregnancy are scarce. Overall, hepatitis A infection during pregnancy is not associated with serious outcomes. However, there is a causal relationship between hepatitis A infection and preterm labour, especially if the infection occurs in the second or third trimester. Hepatitis A infection has also been reported to be associated with other gestational complications such as increased premature uterine contractions, placental abruption, and premature rupture of membranes.

The Department of Health in the UK recommends that hepatitis A vaccine can be given to pregnant women if clinically indicated. Inadvertent exposure to hepatitis A vaccine at any stage in pregnancy is not regarded as medical grounds for termination of pregnancy or any additional fetal monitoring.

Hepatitis A vaccination is recommended for pregnant people with a high risk of HAV-related pregnancy complications

Hepatitis A is an acute and short-term form of viral hepatitis. It is usually mild and self-limiting in healthy adults, but it can pose serious health risks to pregnant people. Contracting hepatitis A during pregnancy can lead to preterm birth, leakage of amniotic fluid, and premature separation of the placenta, among other concerns.

Hepatitis A is transmitted from person to person through contact with infected faeces, often through food or water carrying particles of stool. It can also be transmitted through the faecal-oral route, which may occur during rimming or analingus. Symptoms tend to develop 2–7 weeks after exposure, and most people recover within a few weeks without treatment. However, the virus may survive in the body for up to 6 months and can lead to liver failure in rare cases.

Pregnant people with a high risk of hepatitis A-related pregnancy complications are recommended to receive the hepatitis A vaccine. This includes those who are travelling to areas of moderate to high endemicity, have an increased risk of exposure through lifestyle factors or contact with an infected person, or are expected to have severe outcomes due to pre-existing conditions. The hepatitis A vaccine is an inactivated vaccine, and there is no evidence that it causes harm to the fetus.

The Centers for Disease Control and Prevention (CDC) recommends vaccinating pregnant women who are previously unvaccinated or of unknown vaccination status and are at high risk of contracting hepatitis A. This is to prevent acute liver failure in the mother and minimise the potential risk of transmitting the virus to the fetus. However, limited data is available on the safety of hepatitis A vaccination during pregnancy.

Hepatitis A is a short-term form of viral hepatitis

Unlike hepatitis B and C, hepatitis A does not cause chronic liver disease. However, it can cause debilitating symptoms and, rarely, fulminant hepatitis (acute liver failure), which is often fatal. Almost everyone recovers fully from hepatitis A with lifelong immunity. However, a very small proportion of people infected with hepatitis A could die from fulminant hepatitis.

Hepatitis A infection during pregnancy is not believed to pose a risk to embryo-fetal development. However, there is some evidence that acute infection during the second and third trimesters of pregnancy is associated with gestational complications and preterm labour. Hepatitis A vaccination is recommended for pregnant women at high risk of contracting the infection.

Hepatitis A is transmitted through contact with faeces containing the virus

Hepatitis A is a highly contagious liver disease caused by the hepatitis A virus (HAV). The virus is transmitted through the ingestion of contaminated food and water or through direct contact with an infected person. In particular, the virus is transmitted through the faecal-oral route, which means that an uninfected person can contract the virus by ingesting food or water contaminated by small, undetected amounts of faeces from an infected person. Even consuming microscopic amounts of faeces can spread the hepatitis A virus.

Food and water contamination can occur in several ways. For example, food can be contaminated when it is grown, harvested, or processed if it is improperly handled. Food that is not cooked thoroughly may pass on the virus, and food can also be contaminated after it has been cooked. In families, food can be contaminated through dirty hands when an infected person prepares food for their family members. Waterborne outbreaks, although infrequent, are usually associated with sewage-contaminated or inadequately treated water.

The risk of hepatitis A infection is associated with a lack of safe water and poor sanitation and hygiene, such as contaminated and dirty hands. The spread of hepatitis A can be reduced by having adequate supplies of safe drinking water, proper disposal of sewage within communities, and practising good personal hygiene, such as regular handwashing before meals and after using the bathroom.

In addition to the ingestion of contaminated food and water, hepatitis A can also be transmitted through close physical contact with an infected person, such as through oral-anal sex. However, casual contact among people does not spread the virus.

Hepatitis A vaccination follows the same immunisation schedule used for non-pregnant people

Hepatitis A is an acute, short-term form of viral hepatitis. It is usually mild and self-limiting in healthy adults, but it can pose serious health concerns for pregnant people. Hepatitis A infection during pregnancy is associated with gestational complications and preterm labour, particularly if contracted in the second or third trimester.

The Hepatitis A vaccine is recommended for pregnant people with a high risk of hepatitis A-related pregnancy complications. The vaccine is safe for use during pregnancy and follows the same immunisation schedule used for non-pregnant people. The vaccine is given in a 2- or 3-dose series, with boosters done in multi-week or monthly intervals, as directed by a doctor and the vaccine manufacturer.

Pregnant women can receive the Hepatitis A vaccine if they are travelling to areas of moderate to high endemicity, if they have an increased risk of exposure through lifestyle factors or contact with an infected person, or if they are expected to have severe outcomes.

The Hepatitis A vaccine is an inactivated vaccine, which does not contain a live version of the virus. Overall, the data does not suggest that the vaccine increases the risk of adverse pregnancy outcomes.

Frequently asked questions